BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  PRACS Institute, Ltd. and Alcmaeon Pharma Announce Development Partnership

  October 3, 2012

   · 

  2 min read
• Policy

  AcelRx Pharmaceuticals Receives Notice of Eligibility for Centralized Review From European Medicines Agency for the Sufentanil NanoTab® PCA System

  October 3, 2012

   · 

  5 min read
• Pharm Country

  ContraFect Corporation to Present at the 11th Annual Biotechnology Industry Organization (BIO) Investor Forum

  October 3, 2012

   · 

  2 min read
• Business

  Align Technology, Inc. to Announce Third Quarter Fiscal 2012 Results on October 17, 2012

  October 3, 2012

   · 

  2 min read
• Drug Development

  BioVentrix Initiates Phase II Study of Revivent System for Less Invasive Heart Failure Treatment in Western Europe

  October 3, 2012

   · 

  6 min read
• Business

  Nanophase Technologies Corporation Announces Third Quarter 2012 Financial Conference Call

  October 3, 2012

   · 

  1 min read
• Business

  Intellect Neurosciences, Inc. and iNovacia Enter Research Service Agreement to Evaluate Lead Compounds for CONJUMAB-A Program

  October 3, 2012

   · 

  1 min read
• Genetown

  Tesaro, Inc. Announces Clearance of Investigational New Drug Application for TSR-011

  October 3, 2012

   · 

  1 min read
• Biotech Beach

  Charles Hensley, Ph.D., and Itonis Pharmaceuticals Announce Anti-HIV Compound Targeting the Viral Entry Step

  October 3, 2012

   · 

  2 min read
• CytoDyn Retains Gibraltar Associates for Corporate and Investor Communications

  October 3, 2012

   · 

  1 min read